SCHEMBL3874121

SCHEMBL3874121

C=C[C@@H](CC(=O)O)c1ccc(O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.57
CA2 P00918 1/20 0.39
CAMK2A Q9UQM7 1/20 0.39
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
SRC P12931 1/20 0.38
BACE1 P56817 1/20 0.36
PYGL P06737 1/20 0.36
ESR1 P03372 2/20 0.36
ESR2 Q92731 1/20 0.36
LMNA P02545 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3871935 1.00 FFAR1 (0.57) FFAR1CA2CAMK2AALDH5A1ABAT
SCHEMBL3270768 0.85 FFAR1 (0.52) FFAR1MAPTSRCLMNACYP2D6
SCHEMBL14071758 0.85 FFAR1 (0.52) FFAR1MAPTSRCLMNACYP2D6
SCHEMBL15426947 0.84 FFAR1 (0.56) FFAR1MAPTALDH1A1KDM4ELMNA
SCHEMBL13084164 0.84 FFAR1 (0.49) FFAR1ALDH5A1ABATMAPTALDH1A1
SCHEMBL799352 0.82 NPC1 (0.44) FFAR1ALDH5A1ABATMAPTALDH1A1
SCHEMBL3665015 0.80 FFAR1 (0.59) FFAR1CA2CAMK2AMAPTALDH1A1
SCHEMBL3663042 0.80 FFAR1 (0.59) FFAR1CA2CAMK2AMAPTALDH1A1
SCHEMBL3880133 0.80 FFAR1 (0.59) FFAR1CA2CAMK2AMAPTALDH1A1
SCHEMBL7024971 0.80 FFAR1 (0.80) FFAR1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150299090-A1 SPIRO COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2015-10-22 US disclosed
EP-2139843-B1 SUBSTITUTED BIPHENYL PHENOXY-, THIOPHENYL- AND AMINOPHENYLPROPANOIC ACID GPR40 MODULATORS AMGEN INC (US) 2013-12-25 EP disclosed
US-7572934-B2 Substituted biphenyl GPR40 modulators AMGEN INC. (US) 2009-08-11 US disclosed
US-20090111859-A1 Substituted biphenyl GPR40 modulators AMGEN INC. (US) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111859-A1 Substituted biphenyl GPR40 modulators GPR119, GPR65, GPR55 FFAR1 18/4885CA2 2000/4885CAMK2A 2578/4885
US-20150299090-A1 SPIRO COMPOUNDS AND PHARMACEUTICAL USE THEREOF REN, PKD1, PKD2 FFAR1 2207/4885CA2 959/4885CAMK2A 3333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.